GE Healthcare brings rapid cell characterization to the benchtop with launch of new image cytometry system

23 April 2012

GE Healthcare brings rapid cell characterization to the benchtop with launch of new image cytometry system

 

Cytell™ Image Cytometer designed for research use in cell health, phenotype and antibody assay analyses

Introduces simpler and faster way of working for researchers; frees up specialised cell analysis instruments

Chalfont St Giles, UK – 23 April 2012 – GE Healthcare, the healthcare business of GE (NYSE: GE), announced today the launch of Cytell™ Image Cytometer, a benchtop-sized image cytometer for rapid cell characterization which introduces researchers to a new, simpler, faster and more productive way to conduct their cell analysis. The Cytell system is being unveiled today at Experimental Biology 2012 in San Diego, USA.

The new Cytell™ Image Cytometer enables researchers to capture detailed data about their cells quickly while using minimal sample volumes. Data can be acquired for up to eight samples at a time and results are delivered through an intuitive graphical interface in less than two-and-a-half minutes. The system simplifies researchers’ working practices and increases productivity by removing the need to use specialised cell analysis instruments. Large cell analysis instruments are often in a shared facility, which can be difficult to access at the right time and time-consuming to use.

Dr Amr Abid, General Manager of Cell Technologies, GE Healthcare Life Sciences, said, “We believe that understanding life’s basic building block, the cell, is an essential first step in the development of new and more effective treatments for disease. The Cytell™ Image Cytometer complements our existing advanced cell imaging systems, the IN Cell Analyzer and the DeltaVision^® OMX, by providing a quick and simple option for cell analysis. It is often the small changes that make the difference, and we believe that the Cytell will help researchers save both time and money in an increasingly constrained funding environment.”

For further information please visit www.gelifesciences.com/cytell

About GE Healthcare
GE Healthcare provides transformational medical technologies and services that are shaping a new age of patient care. Our broad expertise in medical imaging and information technologies, medical diagnostics, patient monitoring systems, drug discovery, biopharmaceutical manufacturing technologies, performance improvement and performance solutions services help our customers to deliver better care to more people around the world at a lower cost. In addition, we partner with healthcare leaders, striving to leverage the global policy change necessary to implement a successful shift to sustainable healthcare systems.

Our “healthymagination” vision for the future invites the world to join us on our journey as we continuously develop innovations focused on reducing costs, increasing access and improving quality around the world. Headquartered in the United Kingdom, GE Healthcare is a unit of General Electric Company (NYSE: GE). Worldwide, GE Healthcare employees are committed to serving healthcare professionals and their patients in more than 100 countries.  For more information about GE Healthcare, visit our website at www.gehealthcare.com.